Kingdon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$36.6M |
| 2 |
Alibaba
BABA
|
+$25.9M |
| 3 |
Zebra Technologies
ZBRA
|
+$24.4M |
| 4 |
Aramark
ARMK
|
+$21.1M |
| 5 |
Coty
COTY
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$24M |
| 2 |
SGI
Somnigroup International
SGI
|
+$20.4M |
| 3 |
Keysight
KEYS
|
+$20.2M |
| 4 |
Royal Caribbean
RCL
|
+$17.4M |
| 5 |
RH
RH
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Industrials | 11.95% |
| 3 | Technology | 10.39% |
| 4 | Consumer Discretionary | 9.94% |
| 5 | Materials | 6.06% |
Similar funds
Kingdon Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Kingdon Capital Management held 92 positions worth $1.02B, up 36% from $748M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Kingdon Capital Management deployed $233M of net new capital in Q2 2019, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was Freeport-McMoran: 3,140,882 shares worth $36.5M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Royal Caribbean, an estimated $17.4M trimmed.
- Kingdon Capital Management's largest Q2 2019 buy was Freeport-McMoran: 3,140,882 shares worth $36.5M.
- Kingdon Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019, an estimated $8.86M increase.
- Kingdon Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $17.4M.
- Kingdon Capital Management fully exited Celgene Corp in Q2 2019, selling an estimated $24M.
- Kingdon Capital Management's ten largest holdings make up 44% of its $1.02B portfolio in Q2 2019.
- Kingdon Capital Management opened 31 new positions and closed 24 in Q2 2019.
- Kingdon Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.
Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.